Obeid A - Search Results

1

Outcomes of Eyes With Diabetic Macular Edema That Are Lost to Follow-up After Anti-Vascular Endothelial Growth Factor Therapy.

Matsunaga DR, Salabati M, Obeid A, Wibbelsman TD, Wu C, Mahmoudzadeh R, Ojalvo I, Bilello J, Sivalingam A, Ho AC, Chiang A, Hsu J. Matsunaga DR, et al. Among authors: obeid a. Am J Ophthalmol. 2022 Jan;233:1-7. doi: 10.1016/j.ajo.2021.06.028. Epub 2021 Jul 17. Am J Ophthalmol. 2022. PMID: 34283979

2

Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.

Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, Ho AC, Hsu J. Obeid A, et al. Ophthalmology. 2018 Sep;125(9):1386-1392. doi: 10.1016/j.ophtha.2018.02.034. Epub 2018 Mar 29. Ophthalmology. 2018. PMID: 29606377

3

ENDOPHTHALMITIS AFTER PARS PLANA VITRECTOMY: Efficacy of Intraoperative Subconjunctival Antibiotics.

Weiss SJ, Adam MK, Gao X, Obeid A, Sivalingam A, Fineman MS, Maguire JI, Garg SJ, Haller J, Fischer DH, Hsu J. Weiss SJ, et al. Among authors: obeid a. Retina. 2018 Sep;38(9):1848-1855. doi: 10.1097/IAE.0000000000002175. Retina. 2018. PMID: 29652690

4

External Drainage of Subretinal Fluid During Vitrectomy for Rhegmatogenous Retinal Detachment.

Su D, Obeid A, Hsu J. Su D, et al. Among authors: obeid a. Retina. 2019 Oct;39 Suppl 1:S115-S118. doi: 10.1097/IAE.0000000000002192. Retina. 2019. PMID: 29708935 No abstract available.

5

TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDY.

Obeid A, Hsu J, Ehmann D, Gao X, Sridhar J, Chiang A, Park CH, Ho AC. Obeid A, et al. Retin Cases Brief Rep. 2021 Mar 1;15(2):120-126. doi: 10.1097/ICB.0000000000000752. Retin Cases Brief Rep. 2021. PMID: 29864044

6

Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J; Wills Post Injection Endophthalmitis (PIE) Study Group. Borkar DS, et al. Among authors: obeid a. Am J Ophthalmol. 2018 Oct;194:1-6. doi: 10.1016/j.ajo.2018.06.022. Epub 2018 Jul 6. Am J Ophthalmol. 2018. PMID: 29981738

7

Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.

Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, Fineman MS, Regillo CD, Maguire JI, Garg SJ, Hsu J. Obeid A, et al. Ophthalmology. 2019 Mar;126(3):407-413. doi: 10.1016/j.ophtha.2018.07.027. Epub 2018 Aug 2. Ophthalmology. 2019. PMID: 30077614

8

LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.

Rayess N, Obeid A, Storey PP, Juliano J, Rahimy E, Moshfeghi AA, Garg S, Hsu J. Rayess N, et al. Among authors: obeid a. Retina. 2019 Nov;39(11):2070-2076. doi: 10.1097/IAE.0000000000002300. Retina. 2019. PMID: 30157114

9

Reply.

Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J. Borkar DS, et al. Among authors: obeid a. Am J Ophthalmol. 2018 Dec;196:211-212. doi: 10.1016/j.ajo.2018.08.031. Epub 2018 Sep 28. Am J Ophthalmol. 2018. PMID: 30274784 No abstract available.

10

Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Obeid A, Gao X, Ali FS, Aderman CM, Shahlaee A, Adam MK, Kasi SK, Hyman L, Ho AC, Hsu J. Obeid A, et al. JAMA Ophthalmol. 2018 Nov 1;136(11):1251-1259. doi: 10.1001/jamaophthalmol.2018.3578. JAMA Ophthalmol. 2018. PMID: 30352121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters